Monday, May 27, 2024
- Advertisement -spot_img


translational medicine

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies

MaxCyte granted Legend Biotech a non-exclusive worldwide license to use MaxCyte’s Flow Electroporation® technology and ExPERT™...

ASGCT 2024: SalioGen’s Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides

Jason F. Cole has been working to make gene therapy a reality for patients since he...

Latest news

- Advertisement -spot_img